FEIBA 50U/ML INF PSO LQF 1X1000U + 20ML + BAXJECT

What is the maximum co-payment for FEIBA?

If the insurance company contributes, the maximum co-payment is 0,00 Kč. The maximum pharmacy price is 20 219,42 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.

Does FEIBA have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

20 562,06 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Přípravek je hrazen v léčbě krvácivých stavů způsobených prokázaným inhibitorem faktorů koagulačního systému.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe FEIBA?

hematology and transfusion medicine, pediatric oncology and hematology

What is the composition of FEIBA?

Antiinhibiční komplex koagulačních faktorů (1000 u), lidský plazmatický protein (1200 mg), dihydrát natrium-citrátu, chlorid sodný, voda pro injekci (20 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to FEIBA?

The medicine belongs to ATC group B02BD03 – ANTIINHIBIČNÍ KOMPLEX KOAGULAČNÍCH FAKTORŮ (FEIBA). Medicines with the same active substance can be found here.

Who manufactures FEIBA?

Baxalta Innovations GmbH, Vídeň (A)

Is the medicine in shortage?

The latest report from the manufacturer is from 14. 5. 2025. Production was terminated with effect from 14. 5. 2025. The manufacturer lists medicines with the following code as a potential substitute:

Note provided: Lék v jiné síle.